Rejoinder to the 'Letter to the Editor' on "Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies"

Affiliations

• ¹ Center for Medical Data Science of the Medical University of Vienna, 1090, Vienna, Austria. [email protected].
• ² Faculty of Pharmacy, Universidade de Lisboa, 1649-004, Lisbon, Portugal. [email protected].
• ³ BEBAC, Neubaugasse 36/11, 1070, Vienna, Austria. [email protected].
• ⁴ University of Pretoria, Pretoria, South Africa.
• ⁵ Syneos Health, Bloemfontein, South Africa.
• ⁶ Department of Statistics and Operations Research, Universitat Politecnica de Catalunya. , Barcelona, Catalunya, Spain.
• ⁷ Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada.
• ⁸ Gedeon Richter Plc, Budapest, Hungary.
• ⁹ Consultant, Berlin, Germany.
• ¹⁰ Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
• ¹¹ Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Catalunya, Spain.
• ¹² University of the Free State, Bloemfontein, South Africa.
• ¹³ Hexal - a Sandoz Brand, Holzkirchen, Germany.
• ¹⁴ Quinta-Analytica Yaroslavl, Yaroslavl, Russian Federation.
• ¹⁵ Zakłady Farmaceutyczne Polpharma S.A, Starogard Gdanski, Poland.
• ¹⁶ OnTarget Group, Saint Petersburg, Russian Federation.